Research is at the heart of the National Pork Board’s mission and is funded by your Pork Checkoff dollars. Research is administered in all areas of pork production, processing, and human nutrition to develop a higher quality and more profitable product in the competitive meat protein market.
Learn more about how you can help advance the pork industry through ongoing research.
This study was to evaluate the ability of the vaccine to be lyophilized, and the stability of the vaccine under different storage conditions.
Overall, this study provides data on novel diagnostic sample types in a unique natural consumption model with potential benefits towards enhanced surveillance and early ASFV detection.
Partnering to expand testing capacities, support further evaluation and validation of two commercially available CSF PCR assays, and enhance preparedness across the NAHLN.
In this study, we aim to explore the potential of mRNA vaccine technology for the development of a subunit vaccine against ASFV. For this pilot project, we focused on assessing the immunogenicity of mRNA vaccines containing four well-characterized ASFV antigens: p32, p54, C-type lectin, and CD2v. Each of these antigens plays a distinct role in the viral lifecycle.
The objective of this study was to estimate and compare the diagnostic performance of a novel indirect enzyme-linked immunosorbent assay (iELISA) for ASF serum antibodies (iELISA), developed by Innoceleris Ames, IA, USA and produced and commercialized by Tetracore (Rockville, MD, USA), and the VetAlert™ ASFV DNA Test Kit (qPCR, Tetracore) in both serum and oral fluid (OF) samples collected on farms in Vietnam.
You’re viewing the website for Pork Checkoff and The National Pork Board.
Find information about sustainability and pork industry ethical principles at porkcares.org.
Find pork cooking inspiration at pork.org.